Neurofeedback Market Report 2025

This neurofeedback market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The neurofeedback market size has grown rapidly in recent years. It will grow from $1.42 billion in 2024 to $1.57 billion in 2025 at a compound annual growth rate (CAGR) of 10.7%. The growth in the historic period can be attributed to the prevalence of insomnia and anxiety disorders, increasing mental health awareness, increasing demand due to growing research and clinical validation, rising demand for non-invasive treatment, and increasing healthcare expenditure.

The neurofeedback market size is expected to see rapid growth in the next few years. It will grow to $2.35 billion in 2029 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to the increasing prevalence of mental disorders, increase in the number of traumatic brain injuries, increasing demand for non-pharmacological treatment, growing application in cognitive enhancement, and increasing adoption of home-based therapy. Major trends in the forecast period include advancements in technology, innovating assessment technology, developing cloud-based clinical assessment, miniaturization of electroencephalography (EEG) hardware, and advanced signal processing.

The increasing prevalence of neurodegenerative diseases is expected to drive the growth of the neurofeedback market in the future. Neurodegenerative diseases are conditions that progressively impair the brain and nervous system, affecting memory, movement, and cognitive functions. The rise in these diseases is largely attributed to an aging population, improved diagnosis and awareness, and lifestyle factors. Neurofeedback can be particularly beneficial in managing Parkinson's disease by enhancing motor control, cognitive function, emotional regulation, and overall brain health. It can also improve sleep quality, which is often disrupted in Parkinson's patients, by optimizing brainwave patterns that support restful sleep, thereby aiding in better overall health and symptom management. For example, in December 2022, the Parkinson Foundation reported that the annual incidence of Parkinson's disease (PD) among older adults is 50% higher than the previously estimated 60,000 cases, with predictions suggesting an additional 1.2 million Americans will have Parkinson's disease by 2030. Thus, the growing prevalence of neurodegenerative diseases is fueling the expansion of the neurofeedback market.

Major companies in the neurofeedback market are concentrating on developing cutting-edge devices, such as wireless EEG systems, to enhance data transmission, mobility, and flexibility across different environments. An EEG (Electroencephalogram) device is widely used in neurodegenerative disease research and treatment to monitor brainwave activity and evaluate neurological function. It records the brain's electrical activity through sensors placed on the scalp, helping to identify abnormal brainwave patterns associated with cognitive decline, motor dysfunction, and symptoms of neurodegenerative diseases such as Alzheimer's, Parkinson's, and ALS. For example, in September 2022, BrainBit, a US-based electronics manufacturer, introduced a new wireless EEG device named the BrainBit Flex. This device features four sensors that can be positioned anywhere on the 10-20 system while maintaining high signal quality. The BrainBit Flex improves usability and flexibility, allowing therapists to develop various customized neurofeedback protocols. This innovation broadens the potential for at-home neurofeedback treatment and training, marking a significant advancement for both practitioners and their clients.

In February 2022, Mitsui & Co. Ltd., a Japan-based trading company, acquired NeU Corporation for an undisclosed amount. This acquisition strategically positions Mitsui & Co. Ltd. in the growing neurotechnology sector by incorporating NeU Corporation’s advanced neurofeedback solutions into its portfolio. NeU Corporation, also based in Japan, specializes in brain science solutions, including neurofeedback brain training and related technologies.

Major companies operating in the neurofeedback market are Thought Technology Ltd., NeurOptimal, EMOTIV Inc., EEG Info, ANT Neuro b.v., NeuroCare Group, NeuroSky's, Neuroelectrics Corporation, Brain Master Technologies Inc., Mind Media Inc., Neurofield Inc., Brain Vision LLC, Mitsar Co. Ltd., Mind Alive Inc., Bee Medic LLC, Myndlift, Braincore, Divergent Technologies Inc., MIndfield Biosystems Ltd., NIRx Medical Technologies LLC.

North America was the largest region in the neurofeedback market in 2024. The regions covered in the neurofeedback market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the neurofeedback market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Neurofeedback is a form of biofeedback aimed at training individuals to regulate their brain activity. It involves real-time monitoring of brainwaves, typically through electroencephalography (EEG), to provide feedback on brain function. The objective is to teach the brain to improve its activity regulation, resulting in enhanced cognitive, emotional, and physiological functioning.

The primary types of neurofeedback products include amplifiers, electrodes or sensors, and computer software. Neurofeedback amplifiers are specialized devices that enhance and clarify brain signals collected by electrodes. The different neurofeedback systems include frequency or power neurofeedback systems, slow cortical potential neurofeedback (SCP-NF) systems, low-energy neurofeedback systems (LENS), hemoencephalographic (HEG) neurofeedback systems, live z-score neurofeedback systems, low-resolution electromagnetic tomography (LORE-TA), and functional magnetic resonance imaging (fMRI). These systems are employed in various applications such as treating attention deficit hyperactivity disorder (ADHD), anxiety, depression, epilepsy, insomnia, drug addiction, schizophrenia, and more. They are used by a range of end-users including hospitals, physician offices, and ambulatory surgical centers (ASCs).

The neurofeedback market research report is one of a series of new reports that provides neurofeedback market statistics, including neurofeedback industry global market size, regional shares, competitors with a neurofeedback market share, detailed neurofeedback market segments, market trends, and opportunities, and any further data you may need to thrive in the neurofeedback industry. This neurofeedback research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The neurofeedback market consists of revenues earned by entities by providing home-based neurofeedback, electroencephalogram neurofeedback, alpha-theta neurofeedback, z-score neurofeedback and power neurofeedback. The market value includes the value of related goods sold by the service provider or included within the service offering. The neurofeedback market also includes sales of portable EEG headsets, headbands, caps, and wireless EEG devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.